| DIRECT COMPETITOR COMPARISON | |
| AKRX | ACL | HSP | TEVA | Industry | | Market Cap: | 154.56M | 48.03B | 7.80B | 47.58B | 59.20M | | Employees: | 351 | 15,400 | 14,500 | 38,307 | 56 | | Qtrly Rev Growth (yoy): | -39.20% | 5.90% | 8.90% | 24.90% | 18.90% | | Revenue (ttm): | 83.75M | 6.28B | 3.74B | 12.95B | 12.73M | | Gross Margin (ttm): | 21.29% | 76.53% | 38.02% | 55.30% | 50.63% | | EBITDA (ttm): | -8.94M | 2.51B | 831.40M | 3.94B | -1.76M | | Oper Margins (ttm): | -17.02% | 36.65% | 16.47% | 24.35% | -19.80% | | Net Income (ttm): | -24.72M | 1.97B | 411.80M | 953.00M | N/A | | EPS (ttm): | -0.275 | 6.558 | 2.542 | 1.093 | N/A | | P/E (ttm): | N/A | 24.50 | 18.93 | 49.41 | 23.87 | | PEG (5 yr expected): | N/A | 1.83 | 1.3 | 0.99 | 1.33 | | P/S (ttm): | 1.74 | 7.51 | 2.08 | 3.65 | 3.00 |
|
| ACL = Alcon Inc. | | HSP = Hospira Inc. | | TEVA = Teva Pharmaceutical Industries Limited | | Industry = Diagnostic Substances | |
| BIOTECHNOLOGY COMPANIES RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Amgen Inc. | AMGN | 56.85 | 0.53% | 57.54B | 12.40 | | Genentech, Inc. | Private - View Profile | | Biogen Idec Inc. | BIIB | 48.18 | 1.69% | 13.93B | 16.12 | | Genzyme Corp. | GENZ | 49.98 | -0.58% | 13.26B | 28.49 | | Merck Serono S.A. | Private - View Profile | | Chiron Corporation | Private - View Profile | | Gilead Sciences Inc. | GILD | 46.59 | 0.71% | 41.93B | 18.02 | | MedImmune, Inc. | Private - View Profile | | Life Technologies Corporation | LIFE | 50.64 | 0.78% | 9.03B | 1033.47 | | Teva Pharmaceutical Industries Limited | TEVA | 54.01 | 0.82% | 47.58B | 49.41 |
|
| GENERIC DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Sandoz International GmbH | Private - View Profile | | Watson Pharmaceuticals Inc. | WPI | 37.90 | 1.64% | 4.02B | 19.54 | | King Pharmaceuticals Inc. | KG | 11.72 | 0.43% | 2.91B | N/A | | Ranbaxy Laboratories Limited | Private - View Profile | | Mylan, Inc. | MYL | 17.99 | -1.15% | 5.50B | 110.37 | | Pfizer Inc. | PFE | 18.49 | -0.80% | 149.21B | 15.36 | | Johnson & Johnson | JNJ | 64.36 | 0.31% | 177.58B | 14.06 | | GlaxoSmithKline plc | GSK | 42.75 | 0.73% | 108.37B | 13.49 | | Sanofi-Aventis | SNY | 39.38 | -0.35% | 102.83B | N/A | | Novartis AG | NVS | 55.55 | -0.41% | 126.17B | 16.63 |
|
| DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | RHHBY.PK | 41.42 | -1.03% | N/A | N/A | | AstraZeneca plc | AZN | 46.30 | 1.49% | 67.13B | 9.30 | | Abbott Laboratories | ABT | 53.78 | -0.85% | 83.18B | 14.57 | | Bristol-Myers Squibb Co. | BMY | 25.14 | -0.08% | 49.80B | 13.01 |
|
| NEWS ON DIRECT COMPETITORS | |
| • | ACL | | International Large Cap Equity Picks From Dearborn Partners
Fri 2:22pm -
Wall Street Transcript | | • | HSP | | Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers
Fri 11:06am -
PR Newswire | | • | TEVA | | Cephalon Sues Teva
Fri 9:43am -
Zacks.com | | • | HSP | | TheraDoc acquired by Hospira Inc.
Thu, Dec 3 -
at bizjournals.com | | • | TEVA | | Cubist Pharma rises after upgrade to 'Outperform'
Thu, Dec 3 -
AP | | • | TEVA | | ABT Settles TriCor Dispute with Teva
Thu, Dec 3 -
Zacks.com | | • | TEVA | | Israel Stocks: Israel stocks up; ICL lifts after peers' remarks
Thu, Dec 3 -
at MarketWatch | | • | ACL | | Lihir Gold: A Stellar Options Trade
Thu, Dec 3 -
at Seeking Alpha | | • | TEVA | | Cephalon to Sue Teva for Patent Infringement
Wed, Dec 2 -
at Fox Business | | • | TEVA | | Cephalon sues Teva over sleep drug Nuvigil
Wed, Dec 2 -
AP | | • | ACL | | Wednesday Options Recap
Wed, Dec 2 -
at Seeking Alpha | | • | TEVA | | Tired of Waiting, Teva Advances
Wed, Dec 2 -
at Motley Fool | | • | HSP | | Hospira buys infection monitoring maker TheraDoc
Wed, Dec 2 -
AP | | • | HSP | | Hospira Acquires TheraDoc, Enhances Medication Safety and Infection Management Offerings
Wed, Dec 2 -
PR Newswire | | • | ACL | | Fund Capitalizes On Misunderstandings
Mon, Nov 30 -
Investor's Business Daily | | • | ACL | | 3 Stocks That Just Make Sense
Mon, Nov 30 -
at Motley Fool | | • | HSP | | Cumberland Beats Zacks Estimate
Mon, Nov 30 -
Zacks.com | | • | ACL | | 8 HealthCare Stocks With 3%+ Dividends
Sun, Nov 29 -
at Seeking Alpha | | • | HSP | | Former Cardinal Unit Has Healthy Outlook
Fri, Nov 27 -
Investor's Business Daily | | • | ACL | | The World's Best Dividend Stocks
Wed, Nov 25 -
at Motley Fool | | • | ACL | | Paragon Innovations plans Richardson move
Tue, Nov 24 -
at bizjournals.com | | | All Headlines for these symbols... |
|
|
|
0.22% Nasdaq 
Competitors
